Cargando…

A How-to Guide to Building a Robust SARS-CoV-2 Testing Program at a University-Based Health System

When South Florida became a hot spot for COVID-19 disease in March 2020, we faced an urgent need to develop test capability to detect SARS-CoV-2 infection. We assembled a transdisciplinary team of knowledgeable and dedicated physicians, scientists, technologists, and administrators who rapidly built...

Descripción completa

Detalles Bibliográficos
Autores principales: Nimer, Stephen D., Chapman, Jennifer, Reidy, Lisa, Alencar, Alvaro, Wu, YanYun, Williams, Sion, Pagan, Lazara, Gjolaj, Lauren, MacIntyre, Jessica, Triana, Melissa, Vance, Barbara, Andrews, David, Fan, Yao-Shan, Zhou, Yi, Martinez, Octavio, Garcia-Buitrago, Monica, Cray, Carolyn, Tekin, Mustafa, McCauley, Jacob L., Ruiz, Philip, Pagan, Paola, Lamar, Walter, Alencar, Maritza, Bilbao, Daniel, Prieto, Silvia, Polania, Maritza, Suarez, Maritza, Lujardo, Melissa, Campos, Gloria, Morris, Michele, Shukla, Bhavarth, Caban-Martinez, Alberto, Kobetz, Erin, Parekh, Dipen J., Jorda, Merce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545514/
https://www.ncbi.nlm.nih.gov/pubmed/33088910
http://dx.doi.org/10.1177/2374289520958200
Descripción
Sumario:When South Florida became a hot spot for COVID-19 disease in March 2020, we faced an urgent need to develop test capability to detect SARS-CoV-2 infection. We assembled a transdisciplinary team of knowledgeable and dedicated physicians, scientists, technologists, and administrators who rapidly built a multiplatform, polymerase chain reaction- and serology-based detection program, established drive-through facilities, and drafted and implemented guidelines that enabled efficient testing of our patients and employees. This process was extremely complex, due to the limited availability of needed reagents, but outreach to our research scientists and multiple diagnostic laboratory companies, and government officials enabled us to implement both Food and Drug Administration authorized and laboratory-developed testing–based testing protocols. We analyzed our workforce needs and created teams of appropriately skilled and certified workers to safely process patient samples and conduct SARS-CoV-2 testing and contact tracing. We initiated smart test ordering, interfaced all testing platforms with our electronic medical record, and went from zero testing capacity to testing hundreds of health care workers and patients daily, within 3 weeks. We believe our experience can inform the efforts of others when faced with a crisis situation.